Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesThe Economics of Dialysis in India
Indian Journal of Nephrology, 05/06/09
Khanna U - Chronic kidney disease is a worldwide public health problem, a social calamity and an economic catastrophe. In the year 2000, in the United States (US) alone, about 30 million people were diagnosed with chronic kidney disease (CKD). It is estimated that by 2010, six million worldwide would need renal replacement therapy (RRT) costing 28 billion dollar.
Today in Pharmacoeconomics...keeping you current
Receive free subspecialty "5-minute updates" via email
Treatment of Very Early Rheumatoid Arthritis With Symptomatic Therapy, Disease-Modifying Antirheumatic Drugs, or Biologic Agents. A Cost-Effectiveness Analysis
Annals of Internal Medicine, 11/03/09
Societal cost of rheumatoid arthritis patients in the US
Current Medical Research and Opinion, 11/13/09
Economic evaluation of doripenem for the treatment of nosocomial pneumonia in the US: discrete event simulation
Current Medical Research and Opinion, 11/13/09
Sponsor
Article Search
Sponsor